Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Thera
(NQ:
AXSM
)
87.99
+0.88 (+1.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axsome Thera
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Unveiling 14 Analyst Insights On Axsome Therapeutics
August 22, 2024
Via
Benzinga
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
August 06, 2024
Via
Benzinga
Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
August 05, 2024
AXSM earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
A Glimpse Into The Expert Outlook On Axsome Therapeutics Through 9 Analysts
August 05, 2024
Via
Benzinga
Why Axsome Therapeutics Stock Is Sinking Today
August 05, 2024
Investors were unhappy with Axsome's worse-than-expected Q2 loss.
Via
The Motley Fool
Axsome Plunges On Wide Losses, But Its Biggest Moneymaker Tacks On 135% Growth
August 05, 2024
The company makes treatments for depression and excessive daytime sleepiness.
Via
Investor's Business Daily
Decoding 9 Analyst Evaluations For Axsome Therapeutics
July 18, 2024
Via
Benzinga
Should You Buy This Sinking Stock on the Dip?
June 27, 2024
The biotech isn't having the best year.
Via
The Motley Fool
15 Analysts Assess Axsome Therapeutics: What You Need To Know
June 05, 2024
Via
Benzinga
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
July 24, 2024
Jim Cramer discusses Torm, Trane, Sap and Axsome Therapeutics on CNBC's "Mad Money Lightning Round."
Via
Benzinga
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
July 22, 2024
Needham initiated coverage on Axsome Therapeutics, highlighting its diverse CNS portfolio. The analyst predicts an 8-10x risk-adjusted topline growth in five years, driven by marketed drugs Auvelity...
Via
Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
July 15, 2024
These innovative drugmakers are hard to ignore.
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024.
Via
InvestorPlace
Peeling Back The Layers: Exploring Axsome Therapeutics Through Analyst Insights
April 29, 2024
Via
Benzinga
Analyst Ratings For Axsome Therapeutics
April 10, 2024
Via
Benzinga
2 Under-the-Radar Growth Stocks to Consider
April 10, 2024
Don't ignore these innovative companies.
Via
The Motley Fool
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
July 04, 2024
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.
Via
InvestorPlace
Why Axsome Therapeutics Stock Is Sinking Today
June 11, 2024
A short-seller report is causing a sell-off of the biotech stock.
Via
The Motley Fool
Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
May 28, 2024
Via
Benzinga
3 Monster Stocks in the Making You Can Buy Right Now
May 18, 2024
These stocks might not be small for too much longer.
Via
The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
May 11, 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.
Via
InvestorPlace
Prediction: These 2 Growth Stocks Could Triple By 2030
May 11, 2024
These companies have a habit of silencing the bears.
Via
The Motley Fool
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
May 06, 2024
AXSM earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AXSM Stock Earnings: Axsome Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
AXSM stock results show that Axsome Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
April 30, 2024
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.
Via
InvestorPlace
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?
April 16, 2024
Stocks that work for billionaires aren't necessarily appropriate for every investor.
Via
The Motley Fool
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
March 27, 2024
Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.
Via
InvestorPlace
Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
March 26, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
What's Going On Neurology-Focused Axsome Therapeutics' Stock On Monday?
March 25, 2024
Unlock insights from the SYMPHONY Phase 3 trial of AXS-12 (reboxetine) in narcolepsy patients. AXS-12 demonstrated significant reductions in cataplexy attacks, improved daytime wakefulness, and...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.